Shortening and Improving the Embryonic Stem Cell Test through the Use of Gene Biomarkers of Differentiation
2011

Improving the Embryonic Stem Cell Test with Gene Biomarkers

Sample size: 12 publication 10 minutes Evidence: moderate

Author Information

Author(s): Andrea C. Romero, Eugenio Vilanova, Miguel A. Sogorb

Primary Institution: Unidad de Toxicología y Seguridad Química, Instituto de Bioingeniería, Universidad Miguel Hernández de Elche

Hypothesis

Can gene expression biomarkers improve the embryonic stem cell test (EST) for assessing embryotoxicity?

Conclusion

The study suggests that using gene expression as biomarkers can enhance the EST's predictive ability for embryotoxicity and reduce its duration.

Supporting Evidence

  • 5-fluorouracil was found to be a strong embryotoxicant based on gene expression changes.
  • 5,5-diphenylhydantoin was classified as a weak embryotoxicant.
  • Saccharin was determined to be nonembryotoxic based on the lack of significant gene expression changes.

Takeaway

Scientists found a way to make a test for checking if chemicals are harmful to babies shorter and better by looking at how certain genes behave.

Methodology

The study used D3 embryonic stem cells exposed to various chemicals for 5 days, measuring gene expression and cell viability.

Limitations

The study primarily focused on a limited number of chemicals and may require further validation with additional substances.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1155/2011/286034

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication